Appendix 1: Search strategy for meta-analysis of association between use of angiotensin- converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers and the risk of cancer (as supplied by the authors)
MEDLINE
1. ACEi[ALL]
2. "ACE inhibitors"[ALL]
3. "ACE inhibitor"[ALL]
4. "Angiotensin converting enzyme inhibitor"[ALL]
5. "Angiotensin converting enzyme inhibitors"[ALL]
6. 1 or 2 or 3 or 4 or 5
7. "alacepril"[NM] OR "alacepril"[ALL]
8. "benazepril"[NM] OR "benazepril"[ALL]
9. "captopril"[MH] OR "captopril"[ALL]
10. "ceranapril"[NM] OR "ceranapril"[ALL] OR "ceronapril"[ALL]
11. "cilazapril"[MH] OR "cilazapril"[ALL]
12. "delapril"[NM] OR "delapril"[ALL]
13. "enalapril"[MH] OR "enalapril"[ALL]
14. "fosinopril"[MH] OR "fosinopril"[ALL]
15. "imidapril"[NM] OR "imidapril"[ALL]
16. "lisinopril"[MH] OR "lisinopril"[ALL]
17. "moexipril"[NM] OR "moexipril"[ALL]
18. Moveltipril[ALL]
19. "CGS 13945"[NM] OR "CGS 13945"[ALL] OR "pentopril"[ALL]
20. "perindopril"[MH] OR "perindopril"[ALL]
21. "quinapril"[NM] OR "quinapril"[ALL]
22. "ramipril"[MH] OR "ramipril"[ALL]
23. "spirapril"[NM] OR "spirapril"[ALL]
24. "temocapril hydrochloride"[NM] OR "temocapril hydrochloride"[ALL] OR "temocapril"[ALL]
25. "trandolapril"[NM] OR "trandolapril"[ALL]
26. "zofenopril"[NM] OR "zofenopril"[ALL]
27. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26
28. ARB[ALL]
29. "Angiotensin receptor blocker"[ALL]
30. "Angiotensin receptor blockers"[ALL]
31. "Angiotensin receptor antagonist"[ALL]
Appendix to: Yoon C, Yang HS, Jeon I, et al. Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies. CMAJ 2011. DOI:10.1503/cmaj.101497. Copyright © 2011 Canadian Medical Association or its licensors
2
32. "Angiotensin receptor antagonists"[ALL]
33. "Angiotensin II receptor antagonist"[ALL]
34. "Angiotensin II receptor blocker"[ALL]
35. 28 or 29 or 30 or 31 or 32 or 33 or 34
36. "candesartan"[NM] OR "candesartan"[ALL]
37. "eprosartan"[NM] OR "eprosartan"[ALL]
38. "irbesartan"[NM] OR "irbesartan"[ALL]
39. "losartan"[MH] OR "losartan"[ALL]
40. "olmesartan"[NM] OR "olmesartan"[ALL]
41. "tasosartan"[NM] OR "tasosartan"[ALL]
42. "telmisartan"[NM] OR "telmisartan"[ALL]
43. "valsartan"[NM] OR "valsartan"[ALL]
44. 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43
45. 6 or 27 or 35 or 44
46. "neoplasms"[MH] OR "neoplasms"[ALL] OR "cancer"[ALL]
47. "neoplasm"[ALL]
48. "neoplasia"[ALL]
49. "malignancy"[ALL]
50. Malignant[ALL]
51. "carcinoma"[MH] OR "carcinoma"[ALL]
52. "glioma"[MH] OR "glioma"[ALL]
53. "leukaemia"[ALL] OR "leukemia"[MH] OR "leukemia"[ALL]
54. "lymphoma"[MH] OR "lymphoma"[ALL]
55. "melanoma"[MH] OR "melanoma"[ALL]
56. "meningioma"[MH] OR "meningioma"[ALL]
57. "sarcoma"[MH] OR "sarcoma"[ALL]
58. 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57
59. 45 and 58
60. "humans"[MH]
61. 59 and 60
ALL = All Fields, MH = MeSH Terms, NM = Substance Name
Limitation : Humans
Date of Search : Jan.13.2011 (1974-Jan.2011)
Result : 1031 articles found
Appendix to: Yoon C, Yang HS, Jeon I, et al. Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies. CMAJ 2011. DOI:10.1503/cmaj.101497. Copyright © 2011 Canadian Medical Association or its licensors 3 EMBASE
1. acei
2. 'ace inhibitors'
3. 'ace inhibitor'/de
4. 'angiotensin converting enzyme inhibitor'/de
5. 'angiotensin converting enzyme inhibitors'/de
6. 1 or 2 or 3 or 4 or 5
7. 'alacepril'/de
8. 'benazepril'/de
9. 'captopril'/de
10. 'ceronapril'/de
11. 'cilazapril'/de
12. 'delapril'/de
13. 'enalapril'/de
14. 'fosinopril'/de
15. 'imidapril'/de
16. 'lisinopril'/de
17. 'moexipril'/de
18. moveltipril
19. 'pentopril'/de
20. 'perindopril'/de
21. 'quinapril'/de
22. 'ramipril'/de
23. 'spirapril'/de
24. 'temocapril'/de
25. 'trandolapril'/de
26. 'zofenopril'/de
27. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26
28. arb
29. 'angiotensin receptor blocker'/de
30. 'angiotensin receptor blockers'
31. 'angiotensin receptor antagonist'/de
32. 'angiotensin receptor antagonists'
33. 'angiotensin ii receptor antagonist'/de
34. 'angiotensin ii receptor blocker'/de
35. 28 or 29 or 30 or 31 or 32 or 33 or 34
Appendix to: Yoon C, Yang HS, Jeon I, et al. Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies. CMAJ 2011. DOI:10.1503/cmaj.101497. Copyright © 2011 Canadian Medical Association or its licensors 4 36. 'candesartan'/de
37. 'eprosartan'/de
38. 'irbesartan'/de
39. 'losartan'/de
40. 'olmesartan'/de
41. 'tasosartan'/de
42. 'telmisartan'/de
43. 'valsartan'/de
44. 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43
45. 6 or 27 or 35 or 44
46. 'cancer'/de
47. 'neoplasm'/de
48. 'neoplasia'/de
49. malignancy
50. malignant
51. 'carcinoma'/de
52. 'glioma'/de
53. 'leukemia'/de
54. 'lymphoma'/de
55. 'melanoma'/de
56. 'meningioma'/de
57. 'sarcoma'/de
58. 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57
59. 45 and 58
60. [humans]/lim
61. [embase]/lim OR [embase classic]/lim
62. 59 and 60 and 61
/de = Mapped terms, /lim = Limitation
Limitation : Humans,
Date of Search : Jan.13.2011 (1979-Jan.2011)
Result : 2835 articles found
Appendix to: Yoon C, Yang HS, Jeon I, et al. Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies. CMAJ 2011. DOI:10.1503/cmaj.101497. Copyright © 2011 Canadian Medical Association or its licensors 5 CENTRAL database (The Cochrane Library)
1. acei [ALL]
2. 'ace inhibitors’ [ALL]
3. 'ace inhibitor' [ALL]
4. 'angiotensin converting enzyme inhibitor' [ALL]
5. 'angiotensin converting enzyme inhibitors' [ALL]
6. 1 or 2 or 3 or 4 or 5
7. alacepril [ALL]
8. benazepril [ALL]
9. captopril [ALL]
10. ceronapril [ALL]
11. cilazapril [ALL]
12. delapril [ALL]
13. enalapril [ALL]
14. fosinopril [ALL]
15. imidapril [ALL]
16. lisinopril [ALL]
17. moexipril [ALL]
18. moveltipril [ALL]
19. pentopril [ALL]
20. perindopril [ALL]
21. quinapril [ALL]
22. ramipril [ALL]
23. spirapril [ALL]
24. temocapril [ALL]
25. trandolapril [ALL]
26. zofenopril [ALL]
27. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26
28. arb [ALL]
29. 'angiotensin receptor blocker' [ALL]
30. 'angiotensin receptor blockers' [ALL]
31. 'angiotensin receptor antagonist' [ALL]
32. 'angiotensin receptor antagonists' [ALL]
33. 'angiotensin ii receptor antagonist' [ALL]
34. 'angiotensin ii receptor blocker' [ALL]
35. 28 or 29 or 30 or 31 or 32 or 33 or 34
Appendix to: Yoon C, Yang HS, Jeon I, et al. Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies. CMAJ 2011. DOI:10.1503/cmaj.101497. Copyright © 2011 Canadian Medical Association or its licensors 6 36. candesartan [ALL]
37. eprosartan [ALL]
38. irbesartan [ALL]
39. losartan [ALL]
40. olmesartan [ALL]
41. tasosartan [ALL]
42. telmisartan [ALL]
43. valsartan [ALL]
44. 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43
45. 6 or 27 or 35 or 44
46. cancer [ALL]
47. neoplasm [ALL]
48. neoplasia [ALL]
49. malignancy [ALL]
50. malignant [ALL]
51. carcinoma [ALL]
52. glioma [ALL]
53. leukemia [ALL]
54. lymphoma [ALL]
55. melanoma [ALL]
56. meningioma [ALL]
57. sarcoma [ALL]
58. 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57
59. 45 and 58
[ALL] = in All Text
Limitation : none
Date of Search : Jan.13.2011 (1979-Jan.2011)
Result : 104 articles found
Appendix to: Yoon C, Yang HS, Jeon I, et al. Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies. CMAJ 2011. DOI:10.1503/cmaj.101497. Copyright © 2011 Canadian Medical Association or its licensors